Biotech

All Articles

Former Seagen CEO reveals brand-new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually marketed to Pfizer in 2015 for a...

Ironwood produces more bid for $1B GI medication with new subgroup records

.On the heels of a phase 3 succeed that neglected to blow away investors, Ironwood Pharmaceuticals i...

Novartis inks $150M offer for autoimmune molecular glue

.Don't quit Monte Rosa Therapies right now. The Boston-based biotech is enjoying after signing a tak...

Jade carves out director staff along with Chinook veterinarians-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also ...

Septerna goes public along with upsized offering of $288M

.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the pos...

AbbVie brings in Richter wealthier, paying for $25M to constitute breakthrough contract

.AbbVie has returned to the source of its own antipsychotic goliath Vraylar trying to find one more ...

GenSight enters into ultimate weeks of cash runway as profits flow slips by of range

.GenSight Biologics is weeks off of losing cash. Once more. The biotech simply possesses sufficient ...

AZ licenses discarded rare ailment medicine to Monopar Therapeutics

.Monopar Therapies is actually recouping a medication from the dump of AstraZeneca's uncommon condit...

Arcus' new HIF-2a records in kidney cancer cells mean prospective advantage over Merck's Welireg, professionals claim

.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...

Roche bets approximately $1B to grow Dyno genetics therapy delivery pact

.After forming a genetics therapy alliance with Dyno Rehabs in 2020, Roche is actually back for addi...